| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ARS Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 30,000 | 25 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SPRY | ARS Pharmaceuticals, Inc. | 25 Jun 2025 | 1 | $0 | 4 | Director | 27 Jun 2025, 16:30 |
| SPRY | ARS Pharmaceuticals, Inc. | 20 Jun 2024 | 1 | $0 | 4 | Director | 24 Jun 2024, 17:00 |
| SPRY | ARS Pharmaceuticals, Inc. | 27 Jun 2023 | 1 | $0 | 4 | Director | 28 Jun 2023, 21:00 |
| SPRY | ARS Pharmaceuticals, Inc. | 08 Nov 2022 | 3 | $0 | 4 | Director | 10 Nov 2022, 17:00 |
| SPRY | ARS Pharmaceuticals, Inc. | 08 Nov 2022 | 0 | $0 | 3 | Director | 10 Nov 2022, 16:00 |